Halaven Approved for Late-Stage Breast Cancer

Eisai's Halaven Receives Approval From Swissmedic for Use in Late-Stage Metastatic Breast Cancer: TOKYO, M... http://bit.ly/m8WlRl #drug

Eisai marine sponge derived cancer drug approved in Europe | InPharm

inpharm.com — “Eisai--™s injectible breast cancer drug Halaven has been approved by European regulators.” View full resource at inpharm.com

Most Recently Shared on March 23, 2011 at 3:52 pm By:

Pharmafocus Pharma and Health News

Eisai marine sponge derived cancer drug approved in Europe http://goo.gl/fb/72mhl

MNT Drug Approvals Health News

Halaven(TM) (Eribulin) Receives European Commission Approval For Advanced Breast Cancer

medicalnewstoday.com — “Eisai announced today that it has received approval from the European Commission for Halaven(TM) (Eribulin) for the treatment of patients with locally advanced or metastatic breast cancer who hav” View full resource at medicalnewstoday.com

Most Recently Shared on March 23, 2011 at 12:05 pm By:

Halaven(TM) (Eribulin) Receives European Commission Approval For Advanced Breast Cancer http://mnt.to/3SCy #regulatory

MNT Breast Cancer Health News

The Lancet Publishes Results From Pivotal Study Of Eisai's Halaven™ Injection In Patients With Late-Stage Metastatic Breast Cancer

medicalnewstoday.com — “Eisai announced that results from the global Phase III clinical study EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus Eribulin) will be published online in T” View full resource at medicalnewstoday.com

Most Recently Shared on March 4, 2011 at 11:05 am By:

The Lancet Publishes Results From Pivotal Study Of Eisai's Halaven™ Injection In Patients With Late-Stage Metast... http://mnt.to/3RRf

The Lancet Publishes Results from Pivotal Study of Eisai's Halaven (Eribulin Mesylate) Injection in Patients with Late-Stage Metastatic Breast Cancer - Drugs.com MedNews

drugs.com — “Phase III Study Demonstrated that Halaven Met its Primary Endpoint of Overall Survival (OS) Mar 2, 2011 - Eisai announced today that results from the global Pha” View full resource at drugs.com

Most Recently Shared on March 3, 2011 at 9:11 pm By:

The Lancet Publishes Results from Pivotal Study of Eisai's Halaven (Eribulin Mesylate) Injection in Patien... http://bit.ly/gKR1bv #drug

Eisai looks for $1B from new breast cancer drug - FiercePharma

fiercepharma.com — “Winning the U.S. nod for breast cancer treatment Halaven is just Eisai's first step toward building up the drug. Now FDA-approved for late-stage breast cancer in women who've failed on at least two... Read more...” View full resource at fiercepharma.com

Most Recently Shared on November 16, 2010 at 3:00 pm By:

FiercePharma Health Site

Eisai looks for $1B from new breast cancer drug. http://bit.ly/be4jJJ

FDA approves Eisai breast cancer drug Halaven | InPharm

inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com

Most Recently Shared on November 16, 2010 at 11:05 am By:

Pharmafocus Pharma and Health News

FDA approves Eisai breast cancer drug Halaven http://ht.ly/3arEx

FDA approves new treatment option for late-stage breast cancer

bcriskdoc.tumblr.com — “FDA approves new treatment option for late-stage breast cancer http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm233863.htm?sms_ss=tumblr&at_xt=4ce1f9c24119bc7a,0 Eribulin” View full resource at bcriskdoc.tumblr.com

Most Recently Shared on November 16, 2010 at 3:27 am By:

Mark Robson Oncologist, Hematologist, Physician, Doctor, and Internist

FDA approves new treatment option for late-stage breast cancer - Eribulin http://tumblr.com/xpdq931y7

Medicine and Technology [part of HCPLive]: FDA approves Halaven (eribulin mesylate) for the treatment of metastatic breast cancer

medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Halaven (eribulin mesylate) for the treatment of metastatic breast cancer” View full resource at medicineandtechnology.com

Most Recently Shared on November 16, 2010 at 1:54 am By:

Joseph Kim, MD, MPH Doctor and Physician

FDA approves Halaven (eribulin mesylate) for the treatment of metastatic breast cancer http://goo.gl/fb/HnMlC

FDA Approves Halaven for Late-Stage Breast Cancer

drugs.com — “Halaven (eribulin mesylate) is used to treat metastatic breast cancer. Includes Halaven side effects, interactions and indications.” View full resource at drugs.com

Most Recently Shared on November 16, 2010 at 1:21 am By:

FDA Approves Halaven for Late-Stage Breast Cancer: SILVER SPRING, Md., Nov. 15, 2010 /PRNewswire-USNewswir... http://bit.ly/cMhSdF #drug

FDA Approves Halaven for Late-Stage Breast Cancer

drugs.com — “Halaven (eribulin mesylate) is used to treat metastatic breast cancer. Includes Halaven side effects, interactions and indications.” View full resource at drugs.com

Most Recently Shared on November 16, 2010 at 1:13 am By:

Drugs.com Health Site

FDA Approves Halaven for Late-Stage Breast Cancer - http://bit.ly/d750Fp

Halaven Approved for Late-Stage Breast Cancer - Drugs.com MedNews

drugs.com — “Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration to treat metastatic (spreading) breast cancer among people who have had a” View full resource at drugs.com

Most Recently Shared on November 15, 2010 at 10:11 pm By:

Halaven Approved for Late-Stage Breast Cancer: MONDAY, Nov. 15 -- Halaven (eribulin mesylate) has been app... http://bit.ly/cHsAYn #drug

FDA Approves New Treatment Option for Late-Stage Breast Cancer - Drugs.com MedNews

drugs.com — “SILVER SPRING, Md., Nov. 15, 2010 PRNewswire-USNewswire The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with” View full resource at drugs.com

Most Recently Shared on November 15, 2010 at 10:02 pm By:

FDA Approves New Treatment Option for Late-Stage Breast Cancer: SILVER SPRING, Md., Nov. 15, 2010 /PRNewsw... http://bit.ly/d1WU67 #drug